LOAMU
SAGE

Lombard Odier Asset Management (USA)’s Sage Therapeutics SAGE Stock Holding History

Lombard Odier Asset Management (USA)’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-23,772
Closed -$762K – 244
2016
Q1 		$762K Buy
+23,772
New +$837K 0.1% 137
2015
Q2 		– Sell
-92,089
Closed -$4.63M – 209
2015
Q1 		$4.63M Buy
+92,089
New +$3.96M 0.37% 100

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 17.47% 1-Year Est. Return

Lombard Odier Asset Management (USA)'s SAGE Position: Q2 2016 in Review

Lombard Odier Asset Management (USA) sold out of Sage Therapeutics (SAGE) in Q2 2016, closing a stake of 23,772 shares — an estimated $762K sold.

Lombard Odier Asset Management (USA) first reported a position in SAGE in Q1 2015 and held it in 2 quarters. The position peaked at $4.63M in Q1 2015. 145 funds tracked by Wall St. Rank hold SAGE as of Q2 2016.

  • Lombard Odier Asset Management (USA) reported no remaining Sage Therapeutics position as of Q2 2016 after selling out during the quarter.
  • Lombard Odier Asset Management (USA) sold 23,772 Sage Therapeutics shares in Q2 2016, an estimated $762K.
  • Lombard Odier Asset Management (USA) first reported a position in Sage Therapeutics in Q1 2015 and held it in 2 quarters.
  • Lombard Odier Asset Management (USA)'s Sage Therapeutics position peaked at $4.63M in Q1 2015.
  • 145 funds tracked by Wall St. Rank held Sage Therapeutics as of Q2 2016.

Based on Lombard Odier Asset Management (USA)'s 13F filing for Q2 2016, filed 15 Aug 2016.